NCT03049449 2023-01-18T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing LymphomasNational Institutes of Health Clinical Center (CC)Phase 1 Completed26 enrolled 19 charts
NCT00513474 2017-05-25Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell TransplantMassachusetts General HospitalPhase 1 Completed46 enrolled 11 charts